The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 2,976 | 194,900 | SH | SOLE | 194,900 | 0 | 0 | ||
| ADMA BIOLOGICS INC | COM | 000899104 | 3,751 | 831,731 | SH | SOLE | 831,731 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 6,830 | 6,981,184 | SH | SOLE | 6,981,184 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 17,521 | 5,670,205 | SH | SOLE | 5,670,205 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 17,994 | 2,577,996 | SH | SOLE | 2,577,996 | 0 | 0 | ||
| ALPHATEC HOLDINGS INC | COM NEW | 02081G201 | 2,692 | 903,224 | SH | SOLE | 903,224 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 4,384 | 1,486,002 | SH | SOLE | 1,486,002 | 0 | 0 | ||
| BIOSPECIFICS TECHNOLOGIES | COM | 090931106 | 20,695 | 461,315 | SH | SOLE | 461,315 | 0 | 0 | ||
| CATABASIS PHARMACEUTICALS IN | COM | 14875P107 | 2,302 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 2,213 | 425,531 | SH | SOLE | 425,531 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 770 | 616,109 | SH | SOLE | 616,109 | 0 | 0 | ||
| CANCER GENETICS INC | COM | 13739U104 | 1,239 | 1,391,607 | SH | SOLE | 1,391,607 | 0 | 0 | ||
| CORREVIO PHARMA CORP | COM | 22026V105 | 7,295 | 1,930,022 | SH | SOLE | 1,930,022 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 7,376 | 1,203,339 | SH | SOLE | 1,203,339 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 20,166 | 4,049,298 | SH | SOLE | 4,049,298 | 0 | 0 | ||
| GEMPHIRE THERAPEUTICS INC | COM | 36870A108 | 1,050 | 103,000 | SH | SOLE | 103,000 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 5,506 | 1,689,064 | SH | SOLE | 1,689,064 | 0 | 0 | ||
| MELINTA THERAPEUTICS INC | COM | 58549G100 | 331 | 52,200 | SH | SOLE | 52,200 | 0 | 0 | ||
| INVIVO THERAPEUTICS HOLDINGS | COM PAR | 46186M407 | 132 | 77,900 | SH | SOLE | 77,900 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 6,598 | 1,792,911 | SH | SOLE | 1,792,911 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 5,220 | 1,912,018 | SH | SOLE | 1,912,018 | 0 | 0 | ||
| RIGEL PHARMACEUTICALS INC | COM NEW | 766559603 | 4,235 | 1,496,590 | SH | SOLE | 1,496,590 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 1,393 | 198,373 | SH | SOLE | 198,373 | 0 | 0 | ||
| VIVEVE MEDICAL INC | COM NEW | 92852W204 | 10,471 | 3,849,711 | SH | SOLE | 3,849,711 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 11,430 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||